Immunovia

Rwanda
Byumba, Northern Province, Rwanda

Company profile

Immunovia company profile

Immunovia is a diagnostics company specializing in the early detection of pancreatic cancer. Immunovia conducts clinical trials and validation studies to ensure the accuracy and reliability of their tests. The company collaborates with medical institutions and research centers globally to validate its diagnostic tests and bring them to market. By focusing on early detection, Immunovia aims to significantly impact the treatment and management of pancreatic cancer, potentially improving survival rates. The company's innovative approach to using blood-based biomarkers could pave the way for early detection strategies in other cancers and complex diseases.

Business identity

Contact email
[email protected]
Phone number
+46-46-275 60 00
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$50,000+
Founded
2007-01-01, Year

Headquarters

Country code
RW
Continent
Africa

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$43.5M
Last funding
Grant / $4.5M / 2024-08-05
Last equity funding
Post IPO Equity / $43.5M
Investors
2
Lead investors
2
Founders
1
Articles
162
Exited on
2018-04-03

Founders and investors

Founders

Mats Grahn

Lead investors

EISMEANational Institutes of Health

Investors

EISMEANational Institutes of Health